Stock Research for ENTA


Featured Broker: Ally Invest

Get the due diligence for another stock.


ENTA Stock Chart & Research Data

The ENTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ENTA Due diligence Resources & Stock Charts

The ENTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ENTA Detailed Price Forecast - CNN Money CNN View ENTA Detailed Summary - Google Finance
Yahoo View ENTA Detailed Summary - Yahoo! Finance Zacks View ENTA Stock Research & Analysis -

Stock Analysis

TradeIdeas View ENTA Trends & Analysis - Trade-Ideas Barrons View ENTA Major Holders - Barrons
NASDAQ View ENTA Call Transcripts - NASDAQ Seeking View ENTA Breaking News & Analysis - Seeking Alpha
Spotlight View ENTA Annual Report - OTC Report View ENTA OTC Short Report -
TradeKing View ENTA Fundamentals - TradeKing Charts View ENTA SEC Filings - Bar Chart
WSJ View Historical Prices for ENTA - The WSJ Morningstar View Performance/Total Return for ENTA - Morningstar
MarketWatch View the Analyst Estimates for ENTA - MarketWatch CNBC View the Earnings History for ENTA - CNBC
StockMarketWatch View the ENTA Earnings - StockMarketWatch MacroAxis View ENTA Buy or Sell Recommendations - MacroAxis
Bullish View the ENTA Bullish Patterns - American Bulls Short Pains View ENTA Short Pain Metrics -

Social Media Mentions

StockTwits View ENTA Stock Mentions - StockTwits PennyStocks View ENTA Stock Mentions - PennyStockTweets
Twitter View ENTA Stock Mentions - Twitter Invest Hub View ENTA Investment Forum News - Investor Hub
Yahoo View ENTA Stock Mentions - Yahoo! Message Board Seeking Alpha View ENTA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ENTA - Insider Cow View Insider Transactions for ENTA - Insider Cow
CNBC View ENTA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ENTA - OTC Markets
Yahoo View Insider Transactions for ENTA - Yahoo! Finance NASDAQ View Institutional Holdings for ENTA - NASDAQ

Stock Charts

FinViz View ENTA Stock Insight & Charts - StockCharts View ENTA Investment Charts -
BarChart View ENTA Stock Overview & Charts - BarChart Trading View View ENTA User Generated Charts - Trading View

Latest Financial News for ENTA

Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus
Posted on Tuesday October 23, 2018

Enanta Pharmaceuticals, Inc. (ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that dosing has begun in a Phase 2a study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-938 against respiratory syncytial virus infection in a human challenge study. “RSV is an infection for which there is no safe and effective treatment,” stated Jay R. Luly, Ph.D., President and CEO, Enanta. “Infants, the elderly, and immune compromised individuals are at the highest risk for this severe respiratory tract infection.

How Good Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA), When It Comes To ROE?
Posted on Thursday October 11, 2018

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return

Liver Cancers Rising - Stocks to Watch
Posted on Friday October 05, 2018

HENDERSON, NV / ACCESSWIRE / October 5, 2018 / Liver cancer incidence has more than tripled since 1980. Liver cancer death rates have increased by almost 3% per year since 2000. More than 700,000 people ...

Recent Analysis Shows Enanta Pharmaceuticals, Multi-Color, Otter Tail, Franklin Resources, CubeSmart, and EnPro Industries Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Tuesday September 25, 2018

NEW YORK, Sept. 25, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.